The importance of the genetic picture and globin synthesis in determining the clinical and haematological features of thalassaemia intermedia
- PMID: 427031
- DOI: 10.1111/j.1365-2141.1979.tb05850.x
The importance of the genetic picture and globin synthesis in determining the clinical and haematological features of thalassaemia intermedia
Abstract
Twelve carriers of thalassaemia intermedia were studied. Their clinical and haematological picture was distinctly different from that in both heterozygotes and homozygotes for beta thalassaemia. Several genetic patterns were found responsible for thalassaemia intermedia: beta/delta beta thalassaemia, alpha 2 beta/beta thalassaemia-heterocellular HPFH. In a few subjects the genetic picture indicated that the patients were homozygous for beta thalassaemia, in spite of the mildness of the clinical situation. The lack of genetic uniformity was refelcted in very wide Hb A2 (2.5--8.7%) and Hb F (7.5--96.9%) ranges, as opposed to the noticeable degree of biochemical uniformity indicated by the very similar imbalance of globin chain synthesis: 0.33-0.54 for the non-alpha/alpha chain ratio in the peripheral blood. The mean for this parameter (0.43 +/- 0.05) was significantly different (P less than 0.001) from that observed in heterozygous carriers (0.60 +/- 0.10) and homozygous carriers (0.11 +/- 0.05) for beta thalassaemia. The marrow blood displayed a comparable pattern. It is therefore suggested that the severity of thalassaemia is attributable to the degree of chain synthesis imbalance.
Similar articles
-
Clinical and haematological evaluation of beta thalassaemia intermedia characterised by unusually low Hb F and increased Hb A2: beta thalassaemia intermedia II.J Med Genet. 1985 Jun;22(3):213-21. doi: 10.1136/jmg.22.3.213. J Med Genet. 1985. PMID: 2409284 Free PMC article.
-
Clinical and haematological evaluation of beta thalassaemia intermedia with increased Hb F and Hb A2 in heterozygotes: beta thalassaemia intermedia I.J Med Genet. 1985 Jun;22(3):205-12. doi: 10.1136/jmg.22.3.205. J Med Genet. 1985. PMID: 2409283 Free PMC article.
-
The heterogeneity of normal Hb A2-beta thalassaemia in Greece.Br J Haematol. 1979 May;42(1):109-23. doi: 10.1111/j.1365-2141.1979.tb03703.x. Br J Haematol. 1979. PMID: 465353
-
[Beta thalassemia: molecular pathogenesis and clinical variability].Klin Padiatr. 1991 Jul-Aug;203(4):276-83. doi: 10.1055/s-2007-1025442. Klin Padiatr. 1991. PMID: 1942934 Review. German.
-
Thalassaemia intermedia.Blood Rev. 1987 Dec;1(4):273-9. doi: 10.1016/0268-960x(87)90029-4. Blood Rev. 1987. PMID: 3332112 Review.
Cited by
-
Fetal globin gene inducers: novel agents and new potential.Ann N Y Acad Sci. 2010 Aug;1202:158-64. doi: 10.1111/j.1749-6632.2010.05593.x. Ann N Y Acad Sci. 2010. PMID: 20712788 Free PMC article.
-
Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.Ann N Y Acad Sci. 2005;1054:257-65. doi: 10.1196/annals.1345.033. Ann N Y Acad Sci. 2005. PMID: 16339673 Free PMC article. Clinical Trial.
-
Fetal globin induction--can it cure beta thalassemia?Hematology Am Soc Hematol Educ Program. 2005:38-44. doi: 10.1182/asheducation-2005.1.38. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304357 Free PMC article.
-
Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease.Blood Cells Mol Dis. 2021 Jul;89:102561. doi: 10.1016/j.bcmd.2021.102561. Epub 2021 Mar 12. Blood Cells Mol Dis. 2021. PMID: 33744514 Free PMC article.
-
A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia.Br J Haematol. 2013 May;161(4):587-93. doi: 10.1111/bjh.12304. Epub 2013 Mar 27. Br J Haematol. 2013. PMID: 23530969 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources